Global Liposomal Drug Delivery Device Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04256085

Publication Date:

April 24, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Liposomal Drug Delivery Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淟iposomal Drug Delivery Device Industry Forecast鈥� looks at past sales and reviews total world Liposomal Drug Delivery Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposomal Drug Delivery Device sales for 2025 through 2031. With Liposomal Drug Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomal Drug Delivery Device industry.
This Insight Report provides a comprehensive analysis of the global Liposomal Drug Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liposomal Drug Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Liposomal Drug Delivery Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomal Drug Delivery Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomal Drug Delivery Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomal Drug Delivery Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Segmentation by Application:
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposomal Drug Delivery Device Market Size (2020-2031)
2.1.2 Liposomal Drug Delivery Device Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Liposomal Drug Delivery Device by Country/Region (2020, 2024 & 2031)
2.2 Liposomal Drug Delivery Device Segment by Type
2.2.1 Stealth Liposome Technology
2.2.2 NonPEGylated Liposome Technology
2.2.3 DepoFoam Liposome Technology
2.3 Liposomal Drug Delivery Device Market Size by Type
2.3.1 Liposomal Drug Delivery Device Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Liposomal Drug Delivery Device Market Size Market Share by Type (2020-2025)
2.4 Liposomal Drug Delivery Device Segment by Application
2.4.1 Fungal Diseases
2.4.2 Cancer Therapy
2.4.3 Pain Management
2.4.4 Viral Vaccines
2.4.5 Photodynamic Therapy
2.5 Liposomal Drug Delivery Device Market Size by Application
2.5.1 Liposomal Drug Delivery Device Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Liposomal Drug Delivery Device Market Size Market Share by Application (2020-2025)
3 Liposomal Drug Delivery Device Market Size by Player
3.1 Liposomal Drug Delivery Device Market Size Market Share by Player
3.1.1 Global Liposomal Drug Delivery Device Revenue by Player (2020-2025)
3.1.2 Global Liposomal Drug Delivery Device Revenue Market Share by Player (2020-2025)
3.2 Global Liposomal Drug Delivery Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liposomal Drug Delivery Device by Region
4.1 Liposomal Drug Delivery Device Market Size by Region (2020-2025)
4.2 Global Liposomal Drug Delivery Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposomal Drug Delivery Device Market Size Growth (2020-2025)
4.4 APAC Liposomal Drug Delivery Device Market Size Growth (2020-2025)
4.5 Europe Liposomal Drug Delivery Device Market Size Growth (2020-2025)
4.6 Middle East & Africa Liposomal Drug Delivery Device Market Size Growth (2020-2025)
5 Americas
5.1 Americas Liposomal Drug Delivery Device Market Size by Country (2020-2025)
5.2 Americas Liposomal Drug Delivery Device Market Size by Type (2020-2025)
5.3 Americas Liposomal Drug Delivery Device Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomal Drug Delivery Device Market Size by Region (2020-2025)
6.2 APAC Liposomal Drug Delivery Device Market Size by Type (2020-2025)
6.3 APAC Liposomal Drug Delivery Device Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liposomal Drug Delivery Device Market Size by Country (2020-2025)
7.2 Europe Liposomal Drug Delivery Device Market Size by Type (2020-2025)
7.3 Europe Liposomal Drug Delivery Device Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposomal Drug Delivery Device by Region (2020-2025)
8.2 Middle East & Africa Liposomal Drug Delivery Device Market Size by Type (2020-2025)
8.3 Middle East & Africa Liposomal Drug Delivery Device Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Liposomal Drug Delivery Device Market Forecast
10.1 Global Liposomal Drug Delivery Device Forecast by Region (2026-2031)
10.1.1 Global Liposomal Drug Delivery Device Forecast by Region (2026-2031)
10.1.2 Americas Liposomal Drug Delivery Device Forecast
10.1.3 APAC Liposomal Drug Delivery Device Forecast
10.1.4 Europe Liposomal Drug Delivery Device Forecast
10.1.5 Middle East & Africa Liposomal Drug Delivery Device Forecast
10.2 Americas Liposomal Drug Delivery Device Forecast by Country (2026-2031)
10.2.1 United States Market Liposomal Drug Delivery Device Forecast
10.2.2 Canada Market Liposomal Drug Delivery Device Forecast
10.2.3 Mexico Market Liposomal Drug Delivery Device Forecast
10.2.4 Brazil Market Liposomal Drug Delivery Device Forecast
10.3 APAC Liposomal Drug Delivery Device Forecast by Region (2026-2031)
10.3.1 China Liposomal Drug Delivery Device Market Forecast
10.3.2 Japan Market Liposomal Drug Delivery Device Forecast
10.3.3 Korea Market Liposomal Drug Delivery Device Forecast
10.3.4 Southeast Asia Market Liposomal Drug Delivery Device Forecast
10.3.5 India Market Liposomal Drug Delivery Device Forecast
10.3.6 Australia Market Liposomal Drug Delivery Device Forecast
10.4 Europe Liposomal Drug Delivery Device Forecast by Country (2026-2031)
10.4.1 Germany Market Liposomal Drug Delivery Device Forecast
10.4.2 France Market Liposomal Drug Delivery Device Forecast
10.4.3 UK Market Liposomal Drug Delivery Device Forecast
10.4.4 Italy Market Liposomal Drug Delivery Device Forecast
10.4.5 Russia Market Liposomal Drug Delivery Device Forecast
10.5 Middle East & Africa Liposomal Drug Delivery Device Forecast by Region (2026-2031)
10.5.1 Egypt Market Liposomal Drug Delivery Device Forecast
10.5.2 South Africa Market Liposomal Drug Delivery Device Forecast
10.5.3 Israel Market Liposomal Drug Delivery Device Forecast
10.5.4 Turkey Market Liposomal Drug Delivery Device Forecast
10.6 Global Liposomal Drug Delivery Device Forecast by Type (2026-2031)
10.7 Global Liposomal Drug Delivery Device Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Liposomal Drug Delivery Device Forecast
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Liposomal Drug Delivery Device Product Offered
11.1.3 Novartis AG Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Luye Pharma Group
11.2.1 Luye Pharma Group Company Information
11.2.2 Luye Pharma Group Liposomal Drug Delivery Device Product Offered
11.2.3 Luye Pharma Group Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Luye Pharma Group Main Business Overview
11.2.5 Luye Pharma Group Latest Developments
11.3 Ipsen Pharma
11.3.1 Ipsen Pharma Company Information
11.3.2 Ipsen Pharma Liposomal Drug Delivery Device Product Offered
11.3.3 Ipsen Pharma Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Ipsen Pharma Main Business Overview
11.3.5 Ipsen Pharma Latest Developments
11.4 Celsion, Inc.
11.4.1 Celsion, Inc. Company Information
11.4.2 Celsion, Inc. Liposomal Drug Delivery Device Product Offered
11.4.3 Celsion, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Celsion, Inc. Main Business Overview
11.4.5 Celsion, Inc. Latest Developments
11.5 Galen Limited
11.5.1 Galen Limited Company Information
11.5.2 Galen Limited Liposomal Drug Delivery Device Product Offered
11.5.3 Galen Limited Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Galen Limited Main Business Overview
11.5.5 Galen Limited Latest Developments
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Information
11.6.2 Astellas Pharma, Inc. Liposomal Drug Delivery Device Product Offered
11.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Astellas Pharma, Inc. Main Business Overview
11.6.5 Astellas Pharma, Inc. Latest Developments
11.7 Acrotech Biopharma, Inc.
11.7.1 Acrotech Biopharma, Inc. Company Information
11.7.2 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product Offered
11.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Acrotech Biopharma, Inc. Main Business Overview
11.7.5 Acrotech Biopharma, Inc. Latest Developments
11.8 Fudan-Zhangjiang
11.8.1 Fudan-Zhangjiang Company Information
11.8.2 Fudan-Zhangjiang Liposomal Drug Delivery Device Product Offered
11.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Fudan-Zhangjiang Main Business Overview
11.8.5 Fudan-Zhangjiang Latest Developments
11.9 Pacira
11.9.1 Pacira Company Information
11.9.2 Pacira Liposomal Drug Delivery Device Product Offered
11.9.3 Pacira Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pacira Main Business Overview
11.9.5 Pacira Latest Developments
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Information
11.10.2 Creative Biolabs Liposomal Drug Delivery Device Product Offered
11.10.3 Creative Biolabs Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Creative Biolabs Main Business Overview
11.10.5 Creative Biolabs Latest Developments
11.11 Precision NanoSystems Inc.
11.11.1 Precision NanoSystems Inc. Company Information
11.11.2 Precision NanoSystems Inc. Liposomal Drug Delivery Device Product Offered
11.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Precision NanoSystems Inc. Main Business Overview
11.11.5 Precision NanoSystems Inc. Latest Developments
11.12 Encapsula NanoSciences LLC
11.12.1 Encapsula NanoSciences LLC Company Information
11.12.2 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product Offered
11.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Encapsula NanoSciences LLC Main Business Overview
11.12.5 Encapsula NanoSciences LLC Latest Developments
11.13 Avanti Polar Lipids, Inc.
11.13.1 Avanti Polar Lipids, Inc. Company Information
11.13.2 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product Offered
11.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Avanti Polar Lipids, Inc. Main Business Overview
11.13.5 Avanti Polar Lipids, Inc. Latest Developments
11.14 Viatris Inc.
11.14.1 Viatris Inc. Company Information
11.14.2 Viatris Inc. Liposomal Drug Delivery Device Product Offered
11.14.3 Viatris Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Viatris Inc. Main Business Overview
11.14.5 Viatris Inc. Latest Developments
11.15 Merrimack Pharmaceuticals, Inc
11.15.1 Merrimack Pharmaceuticals, Inc Company Information
11.15.2 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product Offered
11.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Merrimack Pharmaceuticals, Inc Main Business Overview
11.15.5 Merrimack Pharmaceuticals, Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂